Burden of chemotherapy in patients with relapsed/refractory acute myeloid leukemia in the United States: a retrospective claims database study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Burden of chemotherapy in patients with relapsed/refractory acute myeloid leukemia in the United States: a retrospective claims database study

Published:2022-08-04 Issue:9 Volume:15 Page:857-866
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Pandya Bhavik J.¹,Chen Chi-Chang²^ORCID,McGuiness Catherine B.²^ORCID,Sullivan Loretta¹,Feng Qi¹,Walsh Elise²,Borate Uma³

Affiliation:

1. Health Economics and Clinical Outcomes Research-Oncology, Astellas Pharma, Inc, Northbrook, IL, USA

2. Health Economics and Outcomes Research, Real-World Evidence, IQVIA, Plymouth Meeting, PA, USA

3. Oncology, Oregon Health and Science University, Portland, OR, USA

Funder

Astellas Pharma, Inc

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2022.2104709

Reference22 articles.

1. Acute myeloid leukaemia

2. SEER Stat Fact Sheets: acute Myeloid Leukemia [Internet]. Bethesda: MD: National Cancer Institute; [cited 2021 February 26]. Available from: https://seer.cancer.gov/statfacts/html/amyl.html

3. Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

4. Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia

5. Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP